May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Initial Anatomic and Visual Outcomes After One Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration
Author Affiliations & Notes
  • C. C. Robinson
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • A. H. Rogers
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • E. Reichel
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • J. J. Chieh
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • T. Wiegand
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • C. Baumal
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • J. S. Duker
    Retina, Tufts-New England Eye Center, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  C.C. Robinson, None; A.H. Rogers, None; E. Reichel, None; J.J. Chieh, None; T. Wiegand, None; C. Baumal, None; J.S. Duker, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 331. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. C. Robinson, A. H. Rogers, E. Reichel, J. J. Chieh, T. Wiegand, C. Baumal, J. S. Duker; Initial Anatomic and Visual Outcomes After One Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):331. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Keywords: age-related macular degeneration • neovascularization • injection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×